HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Fujise Selected Research

Myocardial Infarction

5/2014Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.
6/2011Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Fujise Research Topics

Disease

2Myocardial Infarction
05/2014 - 06/2011
2Reperfusion Injury
05/2014 - 12/2009
2Infarction (Infarctions)
05/2014 - 12/2009
2Hypoxia (Hypoxemia)
06/2011 - 12/2009
1Ischemia
06/2011
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
04/2010
1Virus Diseases (Viral Diseases)
11/2005
1Infections
11/2005

Drug/Important Bio-Agent (IBA)

2esmolol (Brevibloc)FDA LinkGeneric
05/2014 - 06/2011
2Milrinone (Primacor)FDA LinkGeneric
05/2014 - 06/2011
1adenosine-3',5'-cyclic phosphorothioateIBA
06/2011
1Type 3 Cyclic Nucleotide PhosphodiesterasesIBA
06/2011
1Calcitonin Gene-Related PeptideIBA
04/2010
1D-Penicillamine (2,5)- EnkephalinIBA
12/2009
1Opioid Analgesics (Opioids)IBA
12/2009
1Adrenergic Agents (Adrenergic Drugs)IBA
12/2009
1SynteninsIBA
11/2005
1Proteins (Proteins, Gene)FDA Link
11/2005

Therapy/Procedure

2Therapeutics
05/2014 - 06/2011
1Percutaneous Coronary Intervention
05/2014